Trial Profile
The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2022
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol
- Indications Sedation
- Focus Therapeutic Use
- 16 Aug 2022 Planned End Date changed from 12 Jul 2022 to 12 Jul 2023.
- 16 Aug 2022 Planned primary completion date changed from 11 Jul 2022 to 11 Jul 2023.
- 22 Oct 2021 Status changed from recruiting to active, no longer recruiting.